This microRNA acts as a tumor suppressor in cervical cancer, by down-regulation of CHK1 (checkpoint kinase 1) gene (137) and up-regulation of aprataxin, which leads to radiosensitivity (138). This evidence concerns the gene CHEK1 and cervical carcinoma.